Guerbet Investor Relations Material
Latest events
H2 2023
Guerbet
Q1 2025 TU
24 Apr, 2025
H2 2024
26 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Guerbet SA
Access all reports
Guerbet SA is a France-based healthcare company specializing in the development, manufacture, and distribution of diagnostic imaging products, particularly contrast agents used in medical imaging. Guerbet offers a comprehensive range of imaging solutions for Computed Tomography (CT)/Cath Lab examinations, Magnetic Resonance Imaging (MRI), and interventional imaging. Their product lineup includes iodinated active ingredients for CT/Cath Lab contrast agents and gadolinium complexes for MRI. The company is headquartered in Villepinte, France, and its shares are listed on the Euronext Paris.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
GBT
Country
🇫🇷 France